Release Date: 12/02/13 09:07 Summary: Half Yearly Report and Accounts Price Sensitive: No Download Document 1.14MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%